Bernard A. Fox: What Comes Next for TCR-T and Adoptive Cell Therapy
Bernard A. Fox/LinkedIn

Bernard A. Fox: What Comes Next for TCR-T and Adoptive Cell Therapy

Bernard A. Fox, Co – founder, President, and CEO of UbiVac, shared a post on LinkedIn:

“Great to see my colleague, Dr Eric Tran, the ROCKSTAR who leads the Adoptive Immunotherapy Laboratory at the Earle A. Chiles Research Institute / Providence Cancer Institute joining 3 other CELL Therapy ROCKSTARS : Reagan Jarvis, Harpreet Singh, Michael Kalos speaking in the IO Cell Therapy Plenary.

Rebuilding TCR-T Cell Therapy

Dr. Eric Tran talks about what he sees as the next generation of these cell therapies!
There is a shout out to TIL and Ira Mellman’s talk that mentioned role for TIL.”

Other articles featuring Adoptive Cell Therapy on OncoDaily.